Stada Seeking OTC Acquisitions After Strong 2018 As Private-Equity Owners Begin To Flex Muscles

Germany's Stada is on the look out for consumer health acquisitions globally that can help it reach its ambition to grow faster than the market in 2019. The firm's new private-equity owners are backing CEO Peter Goldschmidt's plan to take the Branded Products division to the next level.

Stada_HQ
• Source: Stada

“Rapid expansion” of its consumer health-focused Branded Products division through acquisitions is a core focus for Stada Arzneimittel AG in 2019 as its private-equity owners look to ramp up sales and earnings at the unit.

Stada is seeking “value-added acquisitions” to grow Branded Products. “These could be pharmaceutical products or entire companies, as long as...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business